PWMG
VRTX icon

Private Wealth Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Private Wealth Management Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.9K Buy
40
+5
+14% +$2.33K ﹤0.01% 369
2025
Q4 		$15.9K Sell
35
-7
-17% -$3.02K ﹤0.01% 380
2025
Q3 		$16.4K Hold
42
– – ﹤0.01% 381
2025
Q2 		$18.7K Sell
42
-1
-2% -$461 0.01% 319
2025
Q1 		$20.8K Sell
43
-1
-2% -$466 0.01% 287
2024
Q4 		$17.7K Buy
44
+2
+5% +$927 0.01% 330
2024
Q3 		$19.5K Buy
42
+1
+2% +$480 0.01% 294
2024
Q2 		$19.2K Buy
41
+7
+21% +$3.04K 0.01% 283
2024
Q1 		$14.2K Hold
34
– – 0.01% 337
2023
Q4 		$13.8K Buy
+34
New +$12.6K 0.01% 334

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Private Wealth Management Group's VRTX Position: Q1 2026 in Review

Private Wealth Management Group increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q1 2026, buying an estimated $2.33K and bringing the position to 40 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Private Wealth Management Group first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $20.8K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Private Wealth Management Group held 40 shares of Vertex Pharmaceuticals worth $17.9K as of Q1 2026.
  • Private Wealth Management Group bought 5 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.33K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q1 2026, its #369 holding.
  • Private Wealth Management Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Private Wealth Management Group's Vertex Pharmaceuticals position peaked at $20.8K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Private Wealth Management Group's 13F filing for Q1 2026, filed 23 Apr 2026.